<PubmedArticle>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">23426496</PMID>
<DateCompleted>
<Year>2013</Year>
<Month>04</Month>
<Day>15</Day>
</DateCompleted>
<DateRevised>
<Year>2018</Year>
<Month>11</Month>
<Day>13</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Electronic">2168-6084</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>149</Volume>
<Issue>2</Issue>
<PubDate>
<Year>2013</Year>
<Month>Feb</Month>
</PubDate>
</JournalIssue>
<Title>JAMA dermatology</Title>
<ISOAbbreviation>JAMA Dermatol</ISOAbbreviation>
</Journal>
<ArticleTitle>New onset of keratoacanthomas after vismodegib treatment for locally advanced basal cell carcinomas: a report of 2 cases.</ArticleTitle>
<Pagination>
<MedlinePgn>242-3</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1001/jamadermatol.2013.1798</ELocationID>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Aasi</LastName>
<ForeName>Sumaira</ForeName>
<Initials>S</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Silkiss</LastName>
<ForeName>Rona</ForeName>
<Initials>R</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Tang</LastName>
<ForeName>Jean Y</ForeName>
<Initials>JY</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Wysong</LastName>
<ForeName>Ashley</ForeName>
<Initials>A</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Liu</LastName>
<ForeName>Andy</ForeName>
<Initials>A</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Epstein</LastName>
<ForeName>Ervin</ForeName>
<Initials>E</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Oro</LastName>
<ForeName>Anthony E</ForeName>
<Initials>AE</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Chang</LastName>
<ForeName>Anne Lynn S</ForeName>
<Initials>AL</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>R01 AR046786</GrantID>
<Acronym>AR</Acronym>
<Agency>NIAMS NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R01 AR052785</GrantID>
<Acronym>AR</Acronym>
<Agency>NIAMS NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R01 CA157895</GrantID>
<Acronym>CA</Acronym>
<Agency>NCI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D002363">Case Reports</PublicationType>
<PublicationType UI="D016422">Letter</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>JAMA Dermatol</MedlineTA>
<NlmUniqueID>101589530</NlmUniqueID>
<ISSNLinking>2168-6068</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000813">Anilides</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000970">Antineoplastic Agents</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C538724">HhAntag691</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D011725">Pyridines</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000369">Aged, 80 and over</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000813">Anilides</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000009">adverse effects</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000627">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000970">Antineoplastic Agents</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000009">adverse effects</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000627">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002280">Carcinoma, Basal Cell</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000188">drug therapy</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007636">Keratoacanthoma</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000139">chemically induced</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008875">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D011725">Pyridines</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000009">adverse effects</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000627">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012878">Skin Neoplasms</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000188">drug therapy</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D016896">Treatment Outcome</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="entrez">
<Year>2013</Year>
<Month>2</Month>
<Day>22</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed">
<Year>2013</Year>
<Month>2</Month>
<Day>22</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2013</Year>
<Month>4</Month>
<Day>16</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">23426496</ArticleId>
<ArticleId IdType="pii">1654876</ArticleId>
<ArticleId IdType="doi">10.1001/jamadermatol.2013.1798</ArticleId>
<ArticleId IdType="pmc">PMC3768013</ArticleId>
<ArticleId IdType="mid">NIHMS509395</ArticleId>
</ArticleIdList>
<ReferenceList>
<Reference>
<Citation>Clin Microbiol Infect. 2010 Sep;16(9):1362-4</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19930272</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>N Engl J Med. 2012 Jan 19;366(3):207-15</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22256804</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Clin Genitourin Cancer. 2009 Jan;7(1):20-3</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19213663</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</PubmedArticle>